When, if at all, do you use nasolacrimal duct stents to prevent stenosis/obstruction when treating skin, sinonasal, or other mid-facial H&N cancers with radiation therapy?
If so, what is your selection criteria? How long do they remain in place?
Do you have any dose constraints to the nasolacrimal duct?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on
I don’t because when the stent is removed, the duct stenoses.
Join for free or sign in to see the full answer